# Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812

> **NCT00411866** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 36 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** SB773812
- **DRUG:** Ketoconazole

## Key facts

- **NCT ID:** NCT00411866
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-13
- **Primary completion:** 2007-10-10
- **Final completion:** 2007-10-10
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00411866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00411866, "Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00411866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*